https://openbell.ai/ 2026-09-17T20:33:02.575Z hourly 1.0 https://openbell.ai/support 2026-09-17T20:33:02.575Z monthly 0.7 https://openbell.ai/privacy 2026-09-17T20:33:02.575Z monthly 0.5 https://openbell.ai/terms 2026-09-17T20:33:02.575Z monthly 0.5 https://openbell.ai/feed.json 2026-09-17T20:33:02.575Z hourly 0.8 https://openbell.ai/news/WHLR:1789677120652 2026-09-17T20:32:00.652Z daily 0.9 https://cdn.brandfetch.io/WHLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Wheeler Real Estate Investment Trust shares are trading lower after the company announced a 1-for-9 reverse stock split. openbell Financial News https://openbell.ai/news/HUBG:1789677065053 2026-09-17T20:31:05.053Z daily 0.9 https://cdn.brandfetch.io/HUBG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hub Group Says It Received Nasdaq Delisting Determination Over Delinquent 10-K And Two 10-Qs; Plans To Appeal By September 23 openbell Financial News https://openbell.ai/news/LOOP:1789677001072 2026-09-17T20:30:01.072Z daily 0.9 https://cdn.brandfetch.io/LOOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 4:30:00 PM ET: Quotation Resumption: News and Resumption Times openbell Financial News https://openbell.ai/news/PXED:1789676658424 2026-09-17T20:24:18.424Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Enters Into Definitive Agreement To Acquire Fuel50 Phoenix Education Partners, Inc. (NYSE: PXED) has entered into a definitive agreement to acquire Fuel50, Inc., an AI-powered workforce transformation platform. The acquisition aims to enhance Fuel50's capabilities and expand its reach with enterprise employers, focusing on AI-powered workforce intelligence and talent mobility. Following the transaction, which is expected to close within 30 days, Fuel50 will operate under its own brand and be led by Co-founder Jo Mills as CEO. Macquarie Capital acted as the exclusive financial advisor for Fuel50 in this transaction. https://openbell.ai/news/PXED:1789676615107 2026-09-17T20:23:35.107Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Partners Acquisition Price For Fuel50 Is $31.5M Cash; Fuel50 Securityholders May Receive Earnout Payments Up To $8.50M Through 2027; Acquisition To Be Funded With Cash On Hand; Fuel50 To Continue Operating Under Its Own Brand After Acquisition On September 16, 2026, Phoenix Education Partners, Inc. announced its agreement to acquire Fuel50 Inc. for approximately $31.5 million in cash, with potential earnout payments of up to $8.5 million through 2027 based on performance milestones. The acquisition will be funded using cash on hand and is expected to close within 30 days, pending customary closing conditions. Fuel50 will continue to operate under its own brand following the acquisition. https://openbell.ai/news/GPRO:1789676404305 2026-09-17T20:20:04.305Z daily 0.9 https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud GoPro Says It Received Nasdaq Notice That It Regained Compliance With $1 Minimum Bid Price Requirement GoPro has announced that it has received a notice from Nasdaq confirming that it has regained compliance with the $1 minimum bid price requirement. This development indicates that the company's stock price has risen above the threshold necessary to meet Nasdaq's listing standards. The compliance is significant for maintaining its listing on the exchange. https://openbell.ai/news/XENE:1789676346036 2026-09-17T20:19:06.036Z daily 0.9 https://cdn.brandfetch.io/XENE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xenon Pharmaceuticals shares are trading lower after the company announced it voluntarily initiated a temporary pause of enrollment of new patients in ongoing psychiatry studies. openbell Financial News https://openbell.ai/news/BIIB:1789676269407 2026-09-17T20:17:49.407Z daily 0.9 https://cdn.brandfetch.io/BIIB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Biogen Announces Publication Of Phase 3 VALIANT Adolescent Subgroup Data In CJASN Demonstrating 75% Proteinuria Reduction For EMPAVELI In Rare Kidney Diseases Biogen Inc. announced the publication of Phase 3 VALIANT study results showing that adolescents treated with EMPAVELI achieved a 75% relative reduction in proteinuria within 6 months compared to placebo. The study, which included nearly half of the adolescent cohort, demonstrated significant improvements in kidney function stabilization. This follows a recent FDA label expansion for EMPAVELI, making it the first approved treatment for adolescents aged 12 and older for both reducing proteinuria and loss of kidney function. https://openbell.ai/news/PXED:1789676260442 2026-09-17T20:17:40.442Z daily 0.9 https://cdn.brandfetch.io/PXED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phoenix Education Enters Into Definitive Agreement To Acquire Fuel50; Terms Undisclosed Phoenix Education Partners, Inc. (NYSE: PXED) has entered into a definitive agreement to acquire Fuel50, an AI-powered workforce transformation platform, with the terms undisclosed. The acquisition aims to enhance Fuel50's capabilities and expand its reach among enterprise employers, focusing on AI-powered workforce intelligence and talent mobility. Following the completion of the transaction, which is expected to close within 30 days, Fuel50 will continue to operate under its own brand, led by Co-founder Jo Mills as CEO. Macquarie Capital acted as the exclusive financial advisor for Fuel50 in this transaction. https://openbell.ai/news/XMAX:1789676253775 2026-09-17T20:17:33.775Z daily 0.9 https://cdn.brandfetch.io/XMAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud XMax's XMax AI Announces Non-Binding Letter Of Cooperation With Korea's apM Group To Develop Fashion-Specific AI Models, Explore Joint Venture openbell Financial News https://openbell.ai/news/IPAR:1789676219498 2026-09-17T20:16:59.498Z daily 0.9 https://cdn.brandfetch.io/IPAR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Interparfums Announces 20-Year Extension Of Exclusive Worldwide Roberto Cavalli And Just Cavalli Fragrance License With Marquee Brands Through December 31, 2046 openbell Financial News https://openbell.ai/news/PBYI:1789676126217 2026-09-17T20:15:26.217Z daily 0.9 https://cdn.brandfetch.io/PBYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Puma Biotechnology Initiates Phase 2 ALISCA-Lung2 Trial Of Alisertib In Advanced Small Cell Lung Cancer Puma Biotechnology, Inc. (NASDAQ: PBYI) has initiated the Phase II ALISCA-Lung2 trial (PUMA-ALI-4202) to evaluate alisertib in combination with paclitaxel for advanced small cell lung cancer. The trial aims to enroll approximately 50 patients who have progressed after platinum-based chemotherapy and immunotherapy. The primary endpoint focuses on the safety and tolerability of the treatment, while secondary endpoints include various measures of treatment efficacy and the evaluation of clinical biomarkers to identify patients who may benefit most. https://openbell.ai/news/PBYI:1789675801084 2026-09-17T20:10:01.084Z daily 0.9 https://cdn.brandfetch.io/PBYI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Puma Biotechnology Initiates ALISertib In CAncer Phase II Trial Of Alisertib In Combination With Paclitaxel For Treatment Of Patients With Advanced Small Cell Lung Cancer Puma Biotechnology, Inc. (NASDAQ: PBYI) has initiated the ALISertib in CAncer (ALISCA®-Lung2) Phase II trial to evaluate alisertib in combination with paclitaxel for patients with advanced small cell lung cancer. The trial will enroll approximately 50 patients who have progressed after platinum-based chemotherapy and immunotherapy, focusing on the safety and tolerability of the treatment. Secondary endpoints will assess response rates, disease control, and survival metrics, while also evaluating clinical biomarkers for patient benefit. https://openbell.ai/news/FERA:1789675764699 2026-09-17T20:09:24.699Z daily 0.9 https://cdn.brandfetch.io/FERA/w/400/h/400?c=1idopYfmtR7ZKg8QMud UPDATE: Fifth Era Acquisition Corp. I Receives Nasdaq Non-Compliance Notice Over Minimum Shareholder Requirement On September 14, 2026, Fifth Era Acquisition Corp. I received a notice from Nasdaq indicating non-compliance with the Minimum Total Holders Requirement, which mandates at least 400 total holders for continued listing. The company has 45 days to submit a plan to regain compliance, with the possibility of a 180-day extension if accepted. If the plan is not accepted, the company can appeal the decision or consider transferring its securities to The Nasdaq Capital Market. This notification does not currently affect the trading of the company's securities. https://openbell.ai/news/FRMI:1789675760510 2026-09-17T20:09:20.510Z daily 0.9 https://cdn.brandfetch.io/FRMI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fermi Says Texas Business Court Denied All Three Temporary Restraining Order Requests From Former CEO Neugebauer Over Bylaw Amendments, Nomination Deadline openbell Financial News https://openbell.ai/news/HDSN:1789675752038 2026-09-17T20:09:12.038Z daily 0.9 https://cdn.brandfetch.io/HDSN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hudson Technologies And Icorium Sign Joint Development Agreement For Extractive Distillation Technology Commercialization openbell Financial News https://openbell.ai/news/COHR:1789675697227 2026-09-17T20:08:17.227Z daily 0.9 https://cdn.brandfetch.io/COHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Coherent Expands Pluggable Optical Line System Portfolio, With Full C-Band, High-Power Variable-Gain Amplifier Optical Line System In Compact QSFP Form Factor Coherent Corp. (NYSE: COHR) has expanded its Pluggable Optical Line System (POLS) portfolio with a new full C-band, high-power variable-gain amplifier optical line system in a compact QSFP form factor. This system supports up to 32 DWDM wavelengths, enabling data rates of up to 25.6Tbps for AI datacenter traffic over distances ranging from 2km to 200km. The enhanced POLS is aimed at meeting the high-capacity interconnect needs of Internet Service and Cloud Hosting Providers, featuring advanced optical transport functions and simplified deployment options. https://openbell.ai/news/LOOP:1789675689085 2026-09-17T20:08:09.085Z daily 0.9 https://cdn.brandfetch.io/LOOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Loop Industries Announces Formation Of Strategic Alternatives Committee To Evaluate Sale, Merger Or Going-Private Transaction; Priority Is India Joint Venture Financing openbell Financial News https://openbell.ai/news/IQST:1789675634009 2026-09-17T20:07:14.009Z daily 0.9 https://cdn.brandfetch.io/IQST/w/400/h/400?c=1idopYfmtR7ZKg8QMud IQSTEL Says Illustrative Model For Microdrama Subscription Business Shows $1.8M To $3.6M In Potential Annualized Profit Contribution At 300,000 Subscribers openbell Financial News https://openbell.ai/news/VSAT:1789675616892 2026-09-17T20:06:56.892Z daily 0.9 https://cdn.brandfetch.io/VSAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Viasat Announces ViaSat-3 F2 Satellite Entered Service Across The Americas, Completing Constellation And Tripling Global Fleet Bandwidth openbell Financial News https://openbell.ai/news/XENE:1789675520462 2026-09-17T20:05:20.462Z daily 0.9 https://cdn.brandfetch.io/XENE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xenon Pharmaceuticals Announces Voluntarily Initiated A Temporary Pause Of Enrollment Of New Patients In Ongoing Psychiatry Studies Following Neuropsychiatric Adverse Events; Patients Currently Enrolled In The Ongoing Studies Remain Active Xenon Pharmaceuticals has voluntarily paused enrollment of new patients in its ongoing clinical studies for major depressive disorder (MDD) and bipolar depression (BPD) due to neuropsychiatric adverse events. Current participants will remain active in the studies, and the pause is a precautionary measure taken in consultation with the Data Safety Monitoring Board. The company is evaluating potential dosing modifications to address these adverse events, which were not previously observed in the Phase 2 X-NOVA study. This action does not affect ongoing studies related to epilepsy. https://openbell.ai/news/LOOP:1789675495007 2026-09-17T20:04:55.007Z daily 0.9 https://cdn.brandfetch.io/LOOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halted at 4:04:54 p.m. ET - Trading Halt: Halt News Pending openbell Financial News https://openbell.ai/news/NHIC:1789675391154 2026-09-17T20:03:11.154Z daily 0.9 https://cdn.brandfetch.io/NHIC/w/400/h/400?c=1idopYfmtR7ZKg8QMud NewHold Investment III Announces Shareholder Approval Of newcleo Business Combination; Expects Close September 21, Nasdaq Trading Under NWCL From September 22 openbell Financial News https://openbell.ai/news/TXN:1789675369502 2026-09-17T20:02:49.502Z daily 0.9 https://cdn.brandfetch.io/TXN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Texas Instruments Increases Quarterly Dividend From $1.42 To $1.52 Per Share Texas Instruments Incorporated (NASDAQ: TXN) announced a 7% increase in its quarterly cash dividend, raising it from $1.42 to $1.52 per share, which annualizes to $6.08. The new dividend will be payable on November 10, 2026, to shareholders of record on October 30, 2026, pending board approval. This marks the 23rd consecutive year of dividend increases for the company, reflecting its commitment to returning free cash flow to shareholders. https://openbell.ai/news/XENE:1789675367284 2026-09-17T20:02:47.284Z daily 0.9 https://cdn.brandfetch.io/XENE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Xenon Pharmaceuticals Submits NDA For Azetukalner In Focal Seizures To FDA Xenon Pharmaceuticals Inc. has submitted a New Drug Application (NDA) for azetukalner to the U.S. FDA for the treatment of focal seizures. This submission is supported by positive results from two clinical trials, showing a significant reduction in monthly seizure frequency compared to placebo. The company has also completed enrollment in the X-NOVA2 study for major depressive disorder (MDD) with approximately 360 patients, and expects topline data in Q1 2027. Additionally, Xenon has paused enrollment for new patients in ongoing psychiatry studies while current participants remain active. https://openbell.ai/news/CSWC:1789675359389 2026-09-17T20:02:39.389Z daily 0.9 https://cdn.brandfetch.io/CSWC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Capital Southwest Says SBA Approved Increase In SBIC II Leverage Commitment From $175M To $250M openbell Financial News https://openbell.ai/news/DRS:1789675325696 2026-09-17T20:02:05.696Z daily 0.9 https://cdn.brandfetch.io/DRS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Leonardo DRS Announces Contract With Doosan Enerbility To Supply Electric Propulsion System For South Korea's KDDX Destroyer Program; Terms Not Disclosed openbell Financial News https://openbell.ai/news/INTA:1789675300536 2026-09-17T20:01:40.536Z daily 0.9 https://cdn.brandfetch.io/INTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Intapp Announces Celeste Plug-In For OpenAI's ChatGPT Enterprise, Available To Eligible Celeste Clients Beginning Today openbell Financial News https://openbell.ai/news/CYCU:1789675256442 2026-09-17T20:00:56.442Z daily 0.9 https://cdn.brandfetch.io/CYCU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cycurion Has Received A Notice Of Allowance For U.S. Patent Titled "Systems And Methods Of Legibly Capturing Vehicle Markings" Cycurion has received a Notice of Allowance for a U.S. patent titled 'Systems and Methods of Legibly Capturing Vehicle Markings.' This development may enhance the company's intellectual property portfolio, potentially impacting its market position. The stock ticker for Cycurion is CYCU. https://openbell.ai/news/OSCR:1789675166877 2026-09-17T19:59:26.877Z daily 0.9 https://cdn.brandfetch.io/OSCR/w/400/h/400?c=1idopYfmtR7ZKg8QMud OSCR stock has given up its prior gain. Oscar Health shares were trading higher after Barclays and Baird raised their respective price targets on the stock. openbell Financial News https://openbell.ai/news/RARE:1789675154110 2026-09-17T19:59:14.110Z daily 0.9 https://cdn.brandfetch.io/RARE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ultragenyx Pharmaceutical shares are trading higher after the company announced the FDA approval of FAYUVI for treatment of pediatric patients with mucopolysaccharidosis type IIIA. openbell Financial News https://openbell.ai/news/DKNG:1789675117895 2026-09-17T19:58:37.895Z daily 0.9 https://cdn.brandfetch.io/DKNG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of sports betting companies are trading lower. The industry may be falling in response to the CFTC's no-action notice that would benefit cryptocurrency trading and prediction markets. openbell Financial News https://openbell.ai/news/RARE:1789675103949 2026-09-17T19:58:23.949Z daily 0.9 https://cdn.brandfetch.io/RARE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ultragenyx Pharmaceutical shares are trading higher after the company announced the FDA approval of FAYUVI for treatment of pediatric patients with mucopolysaccharidosis Type IIIA. openbell Financial News https://openbell.ai/news/MU:1789674908001 2026-09-17T19:55:08.001Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Konskie--Poland---November-21--2024-Micr.jpg?width=250&height=187 Wall Street Expects Micron to Earn $31 A Share This Quarter: That’s 10x From Last Year Micron Technology Inc. (NASDAQ: MU) is projected to report earnings of $31.16 per share for the fiscal fourth quarter, a significant increase from $3.03 per share a year ago, reflecting a 10x year-over-year profit rise. Revenue is expected to reach approximately $50.4 billion, compared to $11.32 billion in the same quarter last year. The company has signed 16 strategic customer agreements, with remaining performance obligations around $100 billion, aiming to stabilize revenue amid fluctuating memory prices. Micron shares are currently trading at about $975, having risen approximately 240% in 2026. https://openbell.ai/news/BTCUSD:1789674895497 2026-09-17T19:54:55.497Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Stack-Of-Bitcoins-And-Handcuffs-Over-Bla.jpg?width=250&height=187 JPMorgan Says Bitcoin Could Beat Gold as Analyst Predicts It'll 'Triple' Gold JPMorgan Chase & Co. analysts indicated that Bitcoin could surpass gold in performance if ETF hedging decreases, with Bloomberg's Eric Balchunas predicting Bitcoin ETFs will eventually triple the assets of gold ETFs. Currently, gold ETFs have fully recovered from 2026 outflows, while Bitcoin ETFs have only recovered about half. The report highlights that Bitcoin still faces more skepticism compared to gold, as evidenced by higher short interest in Bitcoin ETFs and a higher put-to-call ratio for Bitcoin than gold. https://openbell.ai/news/RARE:1789674885201 2026-09-17T19:54:45.201Z daily 0.9 https://cdn.brandfetch.io/RARE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ultragenyx Pharmaceutical Says FDA Grants Standard Full Approval Of FAYUVI For Treatment Of Pediatric Patients With Mucopolysaccharidosis Type IIIA Ultragenyx Pharmaceutical Inc. announced that the FDA has granted standard full approval for FAYUVI (rebisufligene etisparvovec-hopf), the first-ever treatment for pediatric patients with mucopolysaccharidosis type IIIA (Sanfilippo syndrome Type A). This marks Ultragenyx's second gene therapy approval and sixth overall FDA approval. The company will support access through its UltraCare® program, with commercial product expected to ship to Qualified Treatment Centers within 30-60 days. Additionally, Ultragenyx received a Priority Review Voucher upon this approval. https://openbell.ai/news/WDAY:1789674703261 2026-09-17T19:51:43.261Z daily 0.9 https://cdn.brandfetch.io/WDAY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of software companies are trading higher amid overall market strength, falling yields and declining oil prices. openbell Financial News https://openbell.ai/news/APLD:1789674644846 2026-09-17T19:50:44.846Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Applied-Digital-Corporation.jpg?width=250&height=187 Applied Digital Surges After Wells Fargo Names Stock a Top Pick With $50 Price Target Applied Digital Corp (NASDAQ: APLD) shares surged 7.46% to $26.21 following a positive endorsement from Wells Fargo, which initiated coverage with a 'Top Idea' designation and a $50 price target. The report highlighted APLD's competitive advantages in securing utility power allocations and its substantial backlog of $36 billion in long-term lease agreements with major hyperscalers, potentially increasing to $86 billion over 30 years. Analysts noted that APLD trades at a discount to its contracted net asset value, suggesting a strong re-rating opportunity. https://openbell.ai/news/COIN:1789674612707 2026-09-17T19:50:12.707Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of crypto-related companies are trading higher after the SEC announced a five-year exemption for tokenized stock trading. The CFTC also issued a no-action position against passive software providers that partnered with regulated entities and failed to register as brokers. openbell Financial News https://openbell.ai/news/HCTI:1789674530714 2026-09-17T19:48:50.714Z daily 0.9 https://cdn.brandfetch.io/HCTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Healthcare Triangle Partners With Kanzun And ARCB To Connect Malaysian Healthcare Companies To U.S. Capital Markets Healthcare Triangle, Inc. (NASDAQ: HCTI) has partnered with Kanzun Ventures Management and ARCB Investment LLC to facilitate Malaysian healthcare companies' access to U.S. capital markets. The Kanzun-ARCB Growth Fund was launched through a Memorandum of Understanding in Kuala Lumpur, with HCTI responsible for preparing qualifying companies for market entry. ARCB manages approximately AED 300 million in assets and aims to create a structured corridor linking Malaysian healthcare firms to Middle Eastern and U.S. capital. https://openbell.ai/news/FITB:1789673782524 2026-09-17T19:36:22.524Z daily 0.9 https://cdn.brandfetch.io/FITB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fifth Third Bancorp Increases Quarterly Dividend From $0.40 To $0.42 Per Share Fifth Third Bancorp has announced an increase in its quarterly dividend from $0.40 to $0.42 per share, marking the 11th consecutive year of dividend growth. The new dividend will be payable on October 15, 2026, to shareholders of record as of September 30, 2026. The company also declared dividends for various series of preferred shares. https://openbell.ai/news/CPAY:1789673724116 2026-09-17T19:35:24.116Z daily 0.9 https://cdn.brandfetch.io/CPAY/w/400/h/400?c=1idopYfmtR7ZKg8QMud FleetCor Agrees To Pay $100M To Resolve Administrative Action After Federal Court Finds That It Violated The FTC Act By Charging Unauthorized Fees; FTC Alleged That The Company, Now Known As Corpay, Charged Customers Hidden Or Otherwise Unauthorized Fees And Deceived Users About Savings From Its Fuel Cards FleetCor, now known as Corpay, has agreed to pay $100 million to resolve an administrative action after a federal court found it violated the FTC Act by charging unauthorized fees. The Federal Trade Commission (FTC) alleged that the company deceived customers regarding hidden fees and misrepresented savings associated with its fuel cards. This settlement aims to address the deceptive practices identified by the FTC. https://openbell.ai/news/SOS:1789673352196 2026-09-17T19:29:12.196Z daily 0.9 https://cdn.brandfetch.io/SOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud SOS Ltd. Shares Halted, News Pending openbell Financial News https://openbell.ai/news/INTC:1789672874148 2026-09-17T19:21:14.148Z daily 0.9 https://cdn.brandfetch.io/INTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of chip companies are trading higher amid overall market strength, falling yields and declining oil prices. The industry may be boosted by recent talks between Intel and SK Hynix regarding U.S. chip manufacturing. openbell Financial News https://openbell.ai/news/BIAF:1789672405461 2026-09-17T19:13:25.461Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/stock-chart.jpg?width=250&height=187 BioAffinity Technologies Stock Surges Following Hong Kong Patent Grant BioAffinity Technologies Inc. (NASDAQ: BIAF) experienced a significant stock surge of 50.47%, reaching $8.05, following the grant of a key patent in Hong Kong for its CyPath Lung diagnostic. This patent complements an existing patent in China, providing dual intellectual property protection in a region with a high incidence of lung cancer. The CyPath Lung diagnostic has shown robust clinical performance with a 92% sensitivity and is now protected in multiple regions including the U.S., Europe, and Japan. https://openbell.ai/news/MCD:1789672316768 2026-09-17T19:11:56.768Z daily 0.9 https://cdn.brandfetch.io/MCD/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'McDonald’s Is Planning to Revamp Its Value Strategy to Revive US Sales' - Bloomberg McDonald's is set to revamp its value strategy in response to slowing sales growth in the U.S. The company aims to enhance its value menu offerings to attract more customers and improve sales performance. This strategic shift comes as the fast-food giant faces increased competition and changing consumer preferences. https://openbell.ai/news/BE:1789672097775 2026-09-17T19:08:17.775Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Bloom-Energy.jpg?width=250&height=187 Bloom Energy Stock Climbs on Falling Oil and Bond Yields Bloom Energy Corp (NYSE: BE) shares rose 3.69% to $279.99 amid a broader market rebound driven by falling oil prices and bond yields. WTI crude decreased by 1.6% to $100.81 per barrel, while Brent crude fell 2.5% to $103.23, easing inflation concerns and encouraging investment in growth stocks. The Federal Reserve's recent rate increase to a 3.75%-4% range has also contributed to a favorable macro environment for capital-intensive companies like Bloom Energy. https://openbell.ai/news/CACC:1789672026349 2026-09-17T19:07:06.349Z daily 0.9 https://cdn.brandfetch.io/CACC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Credit Acceptance Announces $75.5M Settlement With New York And 40 Other Attorneys General, Plus Debt Relief; Says No Additional Charges Required openbell Financial News https://openbell.ai/news/QXL:1789670036224 2026-09-17T18:33:56.224Z daily 0.9 https://cdn.brandfetch.io/QXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Quantum X Labs shares are trading higher after a Form 4 filing showed its Co-CEO bought 5,000 shares at an average price of $4.88 each. Also, the company launched a multi-dimensional quantum cybersecurity architecture program. openbell Financial News https://openbell.ai/news/PAAI:1789669905172 2026-09-17T18:31:45.172Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/17/Market-volatile-rebound.jpg?width=250&height=187 Paradium.AI Stock Soars on $1 Billion Roundtable Deal Paradium.AI Inc (NYSE: PAAI) shares surged 271.15% to $0.91 following a 10-year, $1 billion deal with RTB Digital Inc (NASDAQ: RTB) to transfer Paradium's media portfolio to Roundtable's AI/DeFi-powered MediaOS. The agreement is expected to generate $100 million in annual revenue and achieve an EBITDA-positive run rate. Additionally, Roundtable will acquire a 49% stake in Paradium for $89 million in cash and stock, with the deal expected to close in the fourth quarter.